As of April 16, 2025, Precigen (PGEN) has a market cap of $0.42 billion USD. According to our data, Precigen is ranked No.6146 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $0.42 B |
29.09%
|
Dec 31, 2024 | $0.33 B |
-16.42%
|
Dec 29, 2023 | $0.39 B |
-11.84%
|
Dec 30, 2022 | $0.45 B |
-59.03%
|
Dec 31, 2021 | $1.09 B |
-63.63%
|
Dec 31, 2020 | $2.99 B |
86.13%
|
Dec 31, 2019 | $1.60 B |
-16.21%
|
Dec 31, 2018 | $1.92 B |
-43.23%
|
Dec 29, 2017 | $3.37 B |
-52.59%
|
Dec 30, 2016 | $7.12 B |
-19.40%
|
Dec 31, 2015 | $8.83 B |
9.52%
|
Dec 31, 2014 | $8.06 B |
15.67%
|
Dec 31, 2013 | $6.97 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Editas Medicine
EDIT
|
$0.11 B |
0.000 M
|
![]() USA
|
![]() CRISPR Therapeutics
CRSP
|
$3.34 B |
0.000 M
|
![]() Switzerland
|
![]() Sangamo Therapeutics
SGMO
|
$0.17 B |
0.000 M
|
![]() USA
|
![]() bluebird bio
BLUE
|
$43.76 M |
0.000 M
|
![]() USA
|
![]() Beam Therapeutics
BEAM
|
$1.73 B |
0.000 M
|
![]() USA
|
![]() Intellia Therapeutics
NTLA
|
$0.76 B |
-0.000 M
|
![]() USA
|
![]() REGENXBIO
RGNX
|
$0.33 B |
-0.000 M
|
![]() USA
|
![]() Allogene Therapeutics
ALLO
|
$0.32 B |
0.000 M
|
![]() USA
|
![]() Cellectis
CLLS
|
$0.18 B |
36.593 M
|
![]() France
|
![]() Precision BioSciences
DTIL
|
$57.86 M |
0.000 M
|
![]() USA
|
![]() Poseida Therapeutics
PSTX
|
$0.93 B |
0.000 M
|
![]() USA
|
![]() Verve Therapeutics
VERV
|
$0.44 B |
-0.000 M
|
![]() USA
|
Market Cap | = | PGEN Stock Price | * | PGEN Shares Outstanding |
= | $1.44 | * | 0.29 B | |
= | $0.42 B |